Academic background&position

data loading...

1. [SCIE] Engineering small-molecule analogs of altiratinib via CRTC3-target screening for the development of potent and safe topical therapeutics against skin hyperpigmentary diseases [Clinical and Translational Medicine] - 2024-03-01
2. [SCIE] Risk of major adverse cardiovascular events and all-cause mortality among patients with psoriatic disease treated with tumor necrosis factor-α and interleukin-12/23 inhibitors: a nationwide population-based cohort study in Korea [JOURNAL OF DERMATOLOGICAL TREATMENT] - 2024-03-01
3. [SCIE] A randomized, double-blinded, vehicle-controlled clinical trial of topical cryosim-1, a synthetic TRPM8 agonist, in prurigo [Journal of Cosmetic Dermatology] - 2024-03-01
4. [SCIE] Comparison of metabolic and neurological comorbidities in Asian patients with psoriasis and atopic dermatitis [SCIENTIFIC REPORTS] - 2024-02-01
5. [SCIE] Risk of incident autoimmune diseases in patients with newly diagnosed psoriatic disease: a nationwide population-based study [SCIENTIFIC REPORTS] - 2023-10-01